Home Forums Industry FDA aims for accelerated approval to allow more drugs

FDA aims for accelerated approval to allow more drugs

Home Forums Industry FDA aims for accelerated approval to allow more drugs

This topic contains 1 reply, has 2 voices, and was last updated by  PhysioT12 1 year, 1 month ago.

  • Author
    Posts
  • #1609

    DD
    Participant

    The FDA has announced its aim to approve more drugs by reducing reviewing cycles to enhance the competition, will this affect the drug quality?

  • #1615

    PhysioT12
    Participant

    Dear DD,

    The FDA has decided to reduce the number of review cycles to help the applicants who can avoid common deficiencies that lead to review delay and application cycle. Moreover, FDA can enhance the competition into market. In one published document the FDA is validating and  reorganizing the review process, including new templates to make each cycle more efficient. According to them they will be taking additional steps to improve their own practices and to assist the industry to make sure their generic drug applications are acted upon as efficiently  possible. Hence, they will not be compromising the quality of the drug.

You must be logged in to reply to this topic.